IBM has acquired acquisition San Mateo, CA-based Compose, Inc., a privately held company that provides MongoDB, Redis, Elasticsearch, PostgreSQL, and other database as a service (DBaaS) offerings targeted at web and mobile app developers. Financial terms were not disclosed.

The cloud database arena is projected to be worth $14 billion by 2019, and open source databases like MongoDB are a significant part -and rapidly growing portion -of this sector. Driving this popularity among developers is the ability to make web and mobile applications easy to build and grow, without the distraction and monotony of back-end database and systems administration.

"Compose's breadth of database offerings will expand IBM's Bluemix platform for the many app developers seeking production-ready databases built on open source," said Derek Schoettle, General Manager, IBM Cloud Data Services. "Compose furthers IBM?s commitment to ensuring developers have access to the right tools for the job by offering the broadest set of DBaaS service and the flexibility of hybrid cloud deployment."

IBM's Cloud Data Services offerings are composable, integrated services for developers that run on the IBM Cloud platform, Bluemix, with DevOps support teams. Compose provides IBM with an enhanced framework to deliver highly sought after, production ready, cloud database services for developers. IBM?s containerized data services approach will further drive the introduction of new Cloud Data Services offerings.

In addition to providing 24x7 monitoring and management by DBaaS DevOps experts, Compose features:

• "Containerized" DBaaS platform technology - enabling fast deployment and scaling of open source DBaaS services;
• Auto-scaling with predictable performance;
• Built-in redundancy, backup, failover for uninterrupted DBaaS service & application uptime;
• Add-ons including Compose Transporter, which helps developers move data between services like MongoDB and Elastic search for easier application development and to provide a better end-user experience.